Global Nuclear Medicine Diagnostics Market is expected to reach $18.2 Oct.2016 | Page 6

Global Nuclear Medicine Diagnostics Market 8.Market Leaders' Analysis 8.1 GE Healthcare 8.1.1 Overview 8.1.2 Product Analysis 8.1.3 Strategic Evaluation and Operations 8.1.4 Financial analysis 8.1.5 Legal issues 8.1.6 Recent Developments 8.1.7 SWOT analysis 8.1.8 Analyst View 8.2 Cardinal Health Inc. 8.3 Bracco Imaging S.p.A 8.4 Eczacibasi-Monrol Nuclear Products 8.5 Nordion, Inc. 8.6 Bayer Healthcare 8.7 Lantheus Medical Imaging, Inc. 8.8 Advanced Accelerator Applications S.A. 8.9 IBA Molecular Imaging 8.10 Mallinckrodt plc. 9.Competitive Landscape 9.1 Market share analysis 9.2 Merger and Acquisition Analysis 9.3 Agreements, collaborations and Joint Ventures 9.4 New Product Launches 10.Expert Opinions 10.1 Market Outlook 10.2 Investment Opportunities Appendix a) List of Tables b) List of Figures [phone] | www.marketdataforecast.com | [email protected]